Evidence & Practice Previous Next
Why ‘watch and wait’ is still a valuable option for low grade lymphomas
Charlotte Bloodworth Haematology clinical nurse specialist, University Hospital of Wales, Heath Park, Cardiff, Wales
In 2016, the National Institute for Health and Care Excellence (NICE) released guidelines recommending people with asymptomatic advanced follicular low grade lymphoma should be offered rituximab monotherapy treatment upfront at diagnosis (
Cancer Nursing Practice. 17, 2, 20-24. doi: 10.7748/cnp.2018.e1445
Correspondencecharlotte.bloodworth@wales.nhs.uk
Conflict of interestNone declared
Peer reviewThis article has been subject to external double-blind review and has been checked for plagiarism using automated software
Write for usFor information about writing for RCNi journals, contact writeforus@rcni.com
For author guidelines, go to rcni.com/writeforus
Received: 30 May 2017
Accepted: 06 September 2017